CTMX — CYTOMX THERAPEUTICS INC

Ownership history in Commodore Capital LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in CYTOMX THERAPEUTICS INC (CTMX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.18% (2025 Q4)
Avg. % of fund
1.54%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 7,692,300 — 0% 2.18% $32.8M $4.26
2025 Q3 UNCHANGED 7,692,300 — 0% 1.20% $24.5M $3.19
2025 Q2 INITIATED 7,692,300 — — 1.23% $17.5M $2.27
% of Fund (quarterly)    CTMX price (monthly, adj. close)

Other funds also holding CTMX

As of 2025 Q4 — sorted by position size

VR Adviser, LLC 3Y 3.27% Kynam Capital Management, LP 3Y 2.44% Exome Asset Management LLC 1.52% ADAR1 Capital Management, LLC 1.29% Ikarian Capital, LLC 3Y 1.06% Elmind Capital, LP 0.88% Vivo Capital, LLC 3Y 7Y 0.79% STEMPOINT CAPITAL LP 0.76% PERCEPTIVE ADVISORS LLC 3Y 7Y 0.74% SCHULHOFF & CO INC 3Y 7Y 0.67%
← Back to Commodore Capital LP Holdings